Top Markets
#1 Black Phoenix Black Phoenix +365.41%
#2 Islamic Coin Islamic Coin +158.18%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +55.15%
#5 Akedo Akedo +35.88%
#6 Acurast Acurast +29.21%
#7 BasedHype BasedHype +27.99%
#8 Cryptopia Cryptopia +21.42%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +21.34%
#10 Quantum Resistant Ledger Quantum Resistant Ledger +20.05%
Coin of the day
Black Phoenix Black Phoenix
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Amarantus BioScience Holdings, Inc. Amarantus BioScience Holdings, Inc.

Amarantus BioScience Holdings, Inc.

AMBS
Xếp hạng trong cổ phiếu #41184
Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm,... Amarantus BioScience Holdings, Inc. operates as a biopharmaceutical firm, concentrating on creating innovative diagnostic tools and therapeutic solutions. Its primary focus areas encompass neurological disorders, psychiatric conditions, eye-related ailments (ophthalmology), and regenerative medicine. The company's diagnostic pipeline includes the LymPro test, a blood-based diagnostic designed to detect Alzheimer's disease by analyzing lymphocyte proliferation, and MSPrecise, a proprietary DNA sequencing assay aimed at identifying individuals with multiple sclerosis. On the therapeutic front, Amarantus is advancing Eltoprazine, a small molecule drug targeting both Levadopa-Induced Dyskinesia in Parkinson's patients and attention deficit hyperactivity disorders (ADHD). Additionally, they are developing a mesencephalic-astrocyte-derived neurotrophic factor (MANF) for treating conditions modeled in animals, such as retinitis pigmentosa and retinal artery occlusion. Amarantus also maintains several specialized platforms: NuroPro, a diagnostic platform dedicated to neurodegenerative diseases with an initial application in Parkinson's; BC-SeraPro, an oncology diagnostic platform specifically for breast cancer; and the PhenoGuard platform, designed for discovering new neurotrophic factors. Beyond these, the company is progressing with Engineered Skin Substitute (ESS), a cell therapy-based product for autologous skin replacement, currently in mid-stage clinical development for severe, life-threatening burns. The company has established a collaborative research and development agreement with both the U.S. Army Institute of Surgical Research and Rutgers University. Established in 2008, Amarantus BioScience Holdings, Inc., which previously operated as Amarantus Bioscience, Inc. until its name change in April 2013, is headquartered in New York, New York.
Giá cổ phiếu
$0.0001
Đồng bộ lần cuối: 2026-08-11
Vốn hóa thị trường
$36.84K
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
-66.67%
Quốc gia
US
Giao dịch Amarantus BioScience Holdings, Inc. (AMBS)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của Amarantus BioScience Holdings, Inc. (AMBS)
Giá đóng cửa cao nhất: $0.00 vào 2026-08-01

Giá đóng cửa thấp nhất: $0.00 vào 2010-09-01
Lịch sử giá cổ phiếu của Amarantus BioScience Holdings, Inc. từ 2010 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) 0.00%
2025 -45.33%
2024 -92.14%
2023 -34.21%
2022 -85.44%
2021 56.94%
2020 -54.01%
2019 -24.76%
2018 -77.87%
2017 235.71%
2016 -95.77%
2015 -94.85%
2014 -99.02%
2013 49,751,484,054.67%
2012 -60.30%
2011 3,461.02%
2010 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.87 33.33%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $873.57 35.10%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $745.48 9.02%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $260.24 16.81%
BE